{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:44:51Z","timestamp":1782971091569,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe pneumonia (SP) threatens the quality of life and well-being of children. This study aims to explore the serum NNT-AS1 expression in SP children and its impact on lipopolysaccharide (LPS)-induced injury in human embryonic lung fibroblasts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included 69 SP children, 62 mild pneumonia (MP) children and 75 healthy controls. A pneumonia cell model was constructed with LPS-induced MRC-5 cells. Loss-of-function experiments were performed using si-NNT-AS1 and miR-23a-3p inhibitor. The NNT-AS1 and miR-23a-3p expression was detected by real-time quantitative polymerase chain reaction. The diagnostic effect and prognostic value of NNT-AS1 were evaluated by receiver operating characteristics curves and Kaplan-Meier method. Cell viability and apoptosis were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry. Inflammatory factors were measured by enzyme-linked immunosorbent assay. The interaction between NNT-AS1 and miR-23a-3p was verified by luciferase reporter gene and RNA immunoprecipitation assays. Pearson correlation coefficient was used to analyze the correlation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NNT-AS1 was upregulated in SP children and showed good diagnostic efficacy (area under the curve (AUC)\u2009=\u20090.815). High NNT\u2011AS1 expression predicted a poorer survival. Silencing of NNT-AS1 increased cell viability, decreased apoptosis, and alleviated inflammatory responses. MiR-23a-3p was a target of NNT-AS1. Inhibition of miR-23a-3p partially reversed the protective effects of NNT-AS1 silencing on LPS-induced MRC-5 cell injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum NNT-AS1 is upregulated in SP patients, and its expression is correlated with clinical prognosis. NNT-AS1 participates in LPS-induced cellular damage by regulating miR-23a-3p. These findings provide a new theoretical basis for understanding the pathogenesis of SP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00683-w","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:03:15Z","timestamp":1778335395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of long non-coding RNA NNT-AS1 in children with severe pneumonia and its effect on lipopolysaccharide-induced human embryonic lung fibroblast injury"],"prefix":"10.1186","volume":"163","author":[{"given":"Fanghua","family":"Jian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"4","key":"683_CR1","first-page":"394","volume":"59","author":"K Spasovska","year":"2021","unstructured":"Spasovska K, Grozdanovski K, Milenkovic Z, Bosilkovski M, Cvetanovska M, Kuzmanovski N, et al. Evaluation of severity scoring systems in patients with severe community acquired pneumonia. Rom J Intern Med. 2021;59(4):394\u2013402.","journal-title":"Rom J Intern Med"},{"issue":"1","key":"683_CR2","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1038\/s41598-017-06739-2","volume":"7","author":"G Huang","year":"2017","unstructured":"Huang G, Huang Q, Xie L, Xiang G, Wang L, Xu H, et al. A rapid, low-cost, and microfluidic chip-based system for parallel identification of multiple pathogens related to clinical pneumonia. Sci Rep. 2017;7(1):6441.","journal-title":"Sci Rep"},{"issue":"12","key":"683_CR3","first-page":"721","volume":"101","author":"JL Hamilton","year":"2020","unstructured":"Hamilton JL, Evans SG, Bakshi M. Management of Fever in Infants and Young Children. Am Fam Physician. 2020;101(12):721\u20139.","journal-title":"Am Fam Physician"},{"key":"683_CR4","first-page":"4852131","volume":"2022","author":"X Wang","year":"2022","unstructured":"Wang X, Lin X. Analysis of Clinical Related Factors of Severe Mycoplasma pneumoniae Pneumonia in Children Based on Imaging Diagnosis. Comput Math Methods Med. 2022;2022:4852131.","journal-title":"Comput Math Methods Med"},{"issue":"1","key":"683_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12879-024-09340-x","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang S, Lu S, Guo Y, Luan W, Liu J, Wang L. A comparative study of general and severe mycoplasma pneumoniae pneumonia in children. BMC Infect Dis. 2024;24(1):449.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"683_CR6","first-page":"771","volume":"38","author":"Y Li","year":"2025","unstructured":"Li Y, Xu D, Yin P. Study on the effect of phentolamine combined with vitamins A\/D on inflammatory responses and humoral immunity in children with severe pneumonia. Pak J Pharm Sci. 2025;38(3):771\u20139.","journal-title":"Pak J Pharm Sci"},{"key":"683_CR7","first-page":"900","volume":"17","author":"M Abbastabar","year":"2018","unstructured":"Abbastabar M, Sarfi M, Golestani A, Khalili E. lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J. 2018;17:900\u201313.","journal-title":"EXCLI J"},{"issue":"19","key":"683_CR8","doi-asserted-by":"publisher","first-page":"23376","DOI":"10.18632\/aging.203632","volume":"13","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liang L, Ji L, Zhang F, Chen D, Duan S, et al. Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p\/ KLF12 axis. Aging. 2021;13(19):23376\u201392.","journal-title":"Aging"},{"issue":"3","key":"683_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/1566524022666220407100949","volume":"23","author":"H Yang","year":"2023","unstructured":"Yang H. Silencing of Long Non-coding RNA H19 Alleviates Lipopolysaccharide (LPS)-induced Apoptosis and Inflammation Injury by Regulating miR-140-5p\/TLR4 Axis in Cell Models of Pneumonia. Curr Mol Med. 2023;23(3):275\u201384.","journal-title":"Curr Mol Med"},{"issue":"2","key":"683_CR10","first-page":"187","volume":"82","author":"Y Cao","year":"2024","unstructured":"Cao Y, Wang F. LncRNA RP11-773H22.4 is upregulated in severe pneumonia and may be a diagnostic and prognostic marker for severe pneumonia. Ann Biol Clin (Paris). 2024;82(2):187\u201399.","journal-title":"Ann Biol Clin (Paris)"},{"issue":"1","key":"683_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12890-021-01609-0","volume":"21","author":"P Wang","year":"2021","unstructured":"Wang P, Zhang H, Zhao W, Dai N. Silencing of long non-coding RNA KCNQ1OT1 alleviates LPS-induced lung injury by regulating the miR-370-3p\/FOXM1 axis in childhood pneumonia. BMC Pulm Med. 2021;21(1):247.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"683_CR12","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.18632\/oncotarget.13840","volume":"8","author":"Q Wang","year":"2017","unstructured":"Wang Q, Yang L, Hu X, Jiang Y, Hu Y, Liu Z, et al. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo. Oncotarget. 2017;8(2):3441\u201353.","journal-title":"Oncotarget"},{"key":"683_CR13","doi-asserted-by":"crossref","unstructured":"Zhou C, Duan S. The Role of Long Non-Coding RNA NNT-AS1 in Neoplastic Disease. Cancers (Basel). 2020;12(11):3086.","DOI":"10.3390\/cancers12113086"},{"issue":"1","key":"683_CR14","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1038\/s41598-021-81853-w","volume":"11","author":"P Chen","year":"2021","unstructured":"Chen P, Huang Z, Chen L, Zhuang S, Lin H, Xie J, et al. The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia in children. Sci Rep. 2021;11(1):2059.","journal-title":"Sci Rep"},{"issue":"3","key":"683_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/1759-7714.13280","volume":"11","author":"W He","year":"2020","unstructured":"He W, Zhang Y, Xia S. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p\/YAP1 axis. Thorac Cancer. 2020;11(3):549\u201360.","journal-title":"Thorac Cancer"},{"issue":"3","key":"683_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10616-021-00471-6","volume":"73","author":"T Pan","year":"2021","unstructured":"Pan T, Xue M. LncRNA-NNT-AS1 contributes to the progression of glioma by miR-582-5p\/EZH2 axis. Cytotechnology. 2021;73(3):473\u201382.","journal-title":"Cytotechnology"},{"issue":"7","key":"683_CR17","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","volume":"53","author":"JS Bradley","year":"2011","unstructured":"Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25\u201376.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"683_CR18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/s44319-023-00051-z","volume":"25","author":"SE Dremel","year":"2024","unstructured":"Dremel SE, Tagawa T, Koparde VN, Hernandez-Perez C, Arbuckle JH, Kristie TM, et al. Interferon induced circRNAs escape herpesvirus host shutoff and suppress lytic infection. EMBO Rep. 2024;25(3):1541\u201369.","journal-title":"EMBO Rep"},{"issue":"35","key":"683_CR19","doi-asserted-by":"publisher","first-page":"e27128","DOI":"10.1097\/MD.0000000000027128","volume":"100","author":"DQ Su","year":"2021","unstructured":"Su DQ, Huang HL, Zhuo ZQ. Pathogen distribution and bacterial resistance in children with severe pneumonia: A single-center retrospective study. Med (Baltim). 2021;100(35):e27128.","journal-title":"Med (Baltim)"},{"issue":"4","key":"683_CR20","doi-asserted-by":"publisher","first-page":"e00825","DOI":"10.1002\/prp2.825","volume":"9","author":"W Yao","year":"2021","unstructured":"Yao W, Zhang X, Xu F, Cao C, Liu T, Xue Y. The therapeutic effects of naringenin on bronchial pneumonia in children. Pharmacol Res Perspect. 2021;9(4):e00825.","journal-title":"Pharmacol Res Perspect"},{"key":"683_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.12659\/AJCR.913430","volume":"20","author":"I Kazama","year":"2019","unstructured":"Kazama I, Nakajima T. Acute Bronchitis Caused by Bordetella Pertussis Possibly Co-Infected with Mycoplasma Pneumoniae. Am J Case Rep. 2019;20:60\u20134.","journal-title":"Am J Case Rep"},{"issue":"8021","key":"683_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-024-07660-1","volume":"631","author":"T Tsukui","year":"2024","unstructured":"Tsukui T, Wolters PJ, Sheppard D. Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis. Nature. 2024;631(8021):627\u201334.","journal-title":"Nature"},{"issue":"1","key":"683_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/arm91010005","volume":"91","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang J. Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis. Adv Respir Med. 2023;91(1):26\u201348.","journal-title":"Adv Respir Med"},{"key":"683_CR24","doi-asserted-by":"crossref","unstructured":"Luo X, Deng Q, Xue Y, Zhang T, Wu Z, Peng H et al. Anti-Fibrosis Effects of Magnesium Lithospermate B in Experimental Pulmonary Fibrosis: By Inhibiting TGF-betaRI\/Smad Signaling. Molecules. 2021;26(6):1715.","DOI":"10.3390\/molecules26061715"},{"key":"683_CR25","doi-asserted-by":"publisher","first-page":"645647","DOI":"10.3389\/fcell.2021.645647","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang W, Min L, Qiu X, Wu X, Liu C, Ma J, et al. Biological Function of Long Non-coding RNA (LncRNA) Xist. Front Cell Dev Biol. 2021;9:645647.","journal-title":"Front Cell Dev Biol"},{"key":"683_CR26","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.2147\/OTT.S237576","volume":"13","author":"H Wang","year":"2020","unstructured":"Wang H, Guo M, Ding D, Yang F, Chen Z. Long Non-Coding RNA NNT-AS1 Contributes to Cisplatin Resistance via miR-1236-3p\/ATG7 Axis in Lung Cancer Cells. Onco Targets Ther. 2020;13:3641\u201352.","journal-title":"Onco Targets Ther"},{"key":"683_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12935-020-01505-3","volume":"20","author":"C Yao","year":"2020","unstructured":"Yao C, Cheng X, Guo X, Lu X, Bu F, Xu Y. NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496\/DDIT4 axis. Cancer Cell Int. 2020;20:463.","journal-title":"Cancer Cell Int"},{"key":"683_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ncrna.2025.01.004","volume":"11","author":"B Chodurska","year":"2025","unstructured":"Chodurska B, Kunej T. Long non-coding RNAs in humans: Classification, genomic organization and function. Noncoding RNA Res. 2025;11:313\u201327.","journal-title":"Noncoding RNA Res"},{"key":"683_CR29","doi-asserted-by":"publisher","first-page":"e11571","DOI":"10.1590\/1414-431x2021e11571","volume":"55","author":"J Ye","year":"2022","unstructured":"Ye J, Feng H, Peng Z. miR-23a-3p inhibits sepsis-induced kidney epithelial cell injury by suppressing Wnt\/beta-catenin signaling by targeting wnt5a. Braz J Med Biol Res. 2022;55:e11571.","journal-title":"Braz J Med Biol Res"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00683-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:30:48Z","timestamp":1782966648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00683-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00683-w","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Qianjiang Central Hospital of Chongqing. Written Informed consent was obtained from legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}